Cargando…

Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer

BACKGROUND: Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Sheila Siqueira, Gouvea, Iuri Estrada, Silva, Mariana Cristina C., Castro, Eloísa Dognani, de Paula, Cláudia A. A., Okamoto, Debora, Oliveira, Lilian, Peres, Giovani Bravin, Ottaiano, Tatiana, Facina, Gil, Nazário, Afonso Celso Pinto, Campos, Antonio Hugo J. F. M., Paredes-Gamero, Edgar Julian, Juliano, Maria, da Silva, Ismael D. C. G., Oliva, Maria Luiza V., Girão, Manoel J. B. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774035/
https://www.ncbi.nlm.nih.gov/pubmed/26931461
http://dx.doi.org/10.1186/s12885-016-2203-7
_version_ 1782418844684386304
author Andrade, Sheila Siqueira
Gouvea, Iuri Estrada
Silva, Mariana Cristina C.
Castro, Eloísa Dognani
de Paula, Cláudia A. A.
Okamoto, Debora
Oliveira, Lilian
Peres, Giovani Bravin
Ottaiano, Tatiana
Facina, Gil
Nazário, Afonso Celso Pinto
Campos, Antonio Hugo J. F. M.
Paredes-Gamero, Edgar Julian
Juliano, Maria
da Silva, Ismael D. C. G.
Oliva, Maria Luiza V.
Girão, Manoel J. B. C.
author_facet Andrade, Sheila Siqueira
Gouvea, Iuri Estrada
Silva, Mariana Cristina C.
Castro, Eloísa Dognani
de Paula, Cláudia A. A.
Okamoto, Debora
Oliveira, Lilian
Peres, Giovani Bravin
Ottaiano, Tatiana
Facina, Gil
Nazário, Afonso Celso Pinto
Campos, Antonio Hugo J. F. M.
Paredes-Gamero, Edgar Julian
Juliano, Maria
da Silva, Ismael D. C. G.
Oliva, Maria Luiza V.
Girão, Manoel J. B. C.
author_sort Andrade, Sheila Siqueira
collection PubMed
description BACKGROUND: Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like transition breast cancer cells and cathepsin K secretion with activation and aggregation of platelets. Cathepsin K is up-regulated in cancer cells that proteolyze extracellular matrix and contributes to invasiveness. Although proteolytically activated receptors (PARs) are activated by proteases, the direct interaction of cysteine cathepsins with PARs is poorly understood. In human platelets, PAR-1 and −4 are highly expressed, but PAR-3 shows low expression and unclear functions. METHODS: Platelet aggregation was monitored by measuring changes in turbidity. Platelets were immunoblotted with anti-phospho and total p38, Src-Tyr-416, FAK-Tyr-397, and TGFβ monoclonal antibody. Activation was measured in a flow cytometer and calcium mobilization in a confocal microscope. Mammary epithelial cells were prepared from the primary breast cancer samples of 15 women with Luminal-B subtype to produce primary cells. RESULTS: We demonstrate that platelets are aggregated by cathepsin K in a dose-dependent manner, but not by other cysteine cathepsins. PARs-3 and −4 were confirmed as the cathepsin K target by immunodetection and specific antagonists using a fibroblast cell line derived from PARs deficient mice. Moreover, through co-culture experiments, we show that platelets activated by cathepsin K mediated the up-regulation of SHH, PTHrP, OPN, and TGFβ in epithelial-mesenchymal-like cells from patients with Luminal B breast cancer. CONCLUSIONS: Cathepsin K induces platelet dysfunction and affects signaling in breast cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2203-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4774035
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47740352016-03-03 Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer Andrade, Sheila Siqueira Gouvea, Iuri Estrada Silva, Mariana Cristina C. Castro, Eloísa Dognani de Paula, Cláudia A. A. Okamoto, Debora Oliveira, Lilian Peres, Giovani Bravin Ottaiano, Tatiana Facina, Gil Nazário, Afonso Celso Pinto Campos, Antonio Hugo J. F. M. Paredes-Gamero, Edgar Julian Juliano, Maria da Silva, Ismael D. C. G. Oliva, Maria Luiza V. Girão, Manoel J. B. C. BMC Cancer Research Article BACKGROUND: Breast cancer comprises clinically and molecularly distinct tumor subgroups that differ in cell histology and biology and show divergent clinical phenotypes that impede phase III trials, such as those utilizing cathepsin K inhibitors. Here we correlate the epithelial-mesenchymal-like transition breast cancer cells and cathepsin K secretion with activation and aggregation of platelets. Cathepsin K is up-regulated in cancer cells that proteolyze extracellular matrix and contributes to invasiveness. Although proteolytically activated receptors (PARs) are activated by proteases, the direct interaction of cysteine cathepsins with PARs is poorly understood. In human platelets, PAR-1 and −4 are highly expressed, but PAR-3 shows low expression and unclear functions. METHODS: Platelet aggregation was monitored by measuring changes in turbidity. Platelets were immunoblotted with anti-phospho and total p38, Src-Tyr-416, FAK-Tyr-397, and TGFβ monoclonal antibody. Activation was measured in a flow cytometer and calcium mobilization in a confocal microscope. Mammary epithelial cells were prepared from the primary breast cancer samples of 15 women with Luminal-B subtype to produce primary cells. RESULTS: We demonstrate that platelets are aggregated by cathepsin K in a dose-dependent manner, but not by other cysteine cathepsins. PARs-3 and −4 were confirmed as the cathepsin K target by immunodetection and specific antagonists using a fibroblast cell line derived from PARs deficient mice. Moreover, through co-culture experiments, we show that platelets activated by cathepsin K mediated the up-regulation of SHH, PTHrP, OPN, and TGFβ in epithelial-mesenchymal-like cells from patients with Luminal B breast cancer. CONCLUSIONS: Cathepsin K induces platelet dysfunction and affects signaling in breast cancer cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2203-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-01 /pmc/articles/PMC4774035/ /pubmed/26931461 http://dx.doi.org/10.1186/s12885-016-2203-7 Text en © Andrade et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Andrade, Sheila Siqueira
Gouvea, Iuri Estrada
Silva, Mariana Cristina C.
Castro, Eloísa Dognani
de Paula, Cláudia A. A.
Okamoto, Debora
Oliveira, Lilian
Peres, Giovani Bravin
Ottaiano, Tatiana
Facina, Gil
Nazário, Afonso Celso Pinto
Campos, Antonio Hugo J. F. M.
Paredes-Gamero, Edgar Julian
Juliano, Maria
da Silva, Ismael D. C. G.
Oliva, Maria Luiza V.
Girão, Manoel J. B. C.
Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
title Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
title_full Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
title_fullStr Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
title_full_unstemmed Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
title_short Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
title_sort cathepsin k induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin k in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774035/
https://www.ncbi.nlm.nih.gov/pubmed/26931461
http://dx.doi.org/10.1186/s12885-016-2203-7
work_keys_str_mv AT andradesheilasiqueira cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT gouveaiuriestrada cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT silvamarianacristinac cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT castroeloisadognani cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT depaulaclaudiaaa cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT okamotodebora cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT oliveiralilian cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT peresgiovanibravin cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT ottaianotatiana cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT facinagil cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT nazarioafonsocelsopinto cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT camposantoniohugojfm cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT paredesgameroedgarjulian cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT julianomaria cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT dasilvaismaeldcg cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT olivamarialuizav cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer
AT giraomanoeljbc cathepsinkinducesplateletdysfunctionandaffectscellsignalinginbreastcancermolecularlydistinctbehaviorofcathepsinkinbreastcancer